Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 3FO6689MSD

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Complement C5 binding agent PubMed ClinicalTrials

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Macular Degeneration 2 D008268 ClinicalTrials
Wet Macular Degeneration 2 D057135 ClinicalTrials
Uveitis, Intermediate 2 D015867 ClinicalTrials
Hemoglobinuria, Paroxysmal 2 D006457 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298012
FDA SRS 3FO6689MSD